CA-CROWN-BIOSCIENCE
Crown Bioscience (CrownBio), a JSR Life Sciences Company, today announced that they have entered into separate, yet complementary, portfolio license agreements with the ATCC and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute (NCI) of the National Institute of Health (NIH). By entering into five-year agreements with these premier biomaterial resource providers, CrownBio clients will directly benefit from a priority status that will make cell lines more readily available with simplified logistics.
Through its XenoSelect™ and OmniScreen™ panels, CrownBio already offers its clients highly customizable, broad in vitro screening panel services, paired with industry-leading bioinformatics capabilities and a breadth of established “matched” downstream in vivo models. CrownBio clients will now have access to an extended and unrivaled portfolio of cell lines, with the knowledge and peace of mind that all necessary licensing is in place.
The license agreement with ATCC grants CrownBio expedited access to more than 140 cell lines and associated datasets, as well as future access to an additional 4000 cell lines through an umbrella licensing structure. Similarly, to meet CrownBio’s ongoing global client needs for supplies of NIH cell lines, a new portfolio license has been signed with the NIH. With this agreement, CrownBio will provide access to 100 cell lines available through the NCI Repository of Tumors and Tumor Cell Lines and other sources, that were developed in NCI labs.
Henry Li, PhD, CSO of CrownBio said, “We greatly value our relationships with both ATCC and NIH, which are two of CrownBio’s largest cell line partners. We are excited that these new agreements will enable us to offer our clients expanded and prioritized cell line availability and supply. Together, these agreements exemplify CrownBio’s dedication to ensuring our clients have easy access to an industry-leading range of in vitro and in vivo models for drug discovery.”
###
About Crown Bioscience
Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology, immuno-oncology and immune-mediated inflammatory disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. For more information, visit: www.crownbio.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210603005538/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Visa Live Takes Flight with Benson Boone at the Rocket Garden22.10.2025 17:30:00 CEST | Press release
From le Louvre to the Launch Pad, Visa Live returns with another unforgettable music experience that puts fans at the center of the action. Prepare for lift-off this November as Visa presents another unforgettable cultural moment with Visa Live at the Rocket Gardenfeaturing global chart-topping sensation, Benson Boone on November 29. After the global success of Visa Live at le Louvre, the next chapter of the series lands at one of the world’s most iconic locations, the Rocket Garden at Kennedy Space Center Visitor Complex in Merritt Island, Florida. Headlined by Benson Boone, with a special guest to be announced, this event will be livestreamed on TikTok, inviting fans everywhere to join a night of music under the stars in a setting typically reserved for daylight exploration. “The Visa Live experience speaks to a fundamental truth in music: the space or environment in which the music is performed actually matters to both the artist and the audience,” said Frank Cooper III, Chief Marke
Stronghold's SHx Token Lists on Kraken Exchange22.10.2025 17:30:00 CEST | Press release
Driving the Next Wave of Fintech Innovation: Infrastructure Leader Expands Access to Utility Token Stronghold today announced that its SHx token is now available for trading on Kraken, one of the world's most trusted and secure cryptocurrency exchanges. Trading begins at 8:00 AM PST, marking SHx's first listing on a U.S.-based exchange and a significant expansion in accessibility for the token that powers payments, settlements, and community governance within the Stronghold ecosystem. "Listing on Kraken brings SHx to one of crypto's most sophisticated audiences, traders, and builders who understand utility-driven tokens. This is about liquidity, interoperability, and connecting our real-world payment infrastructure to a platform that shares our commitment to security, compliance, and transparency." — Tammy Camp, CEO & Co-Founder, Stronghold SHx operates on the Stellar blockchain as Stronghold's native utility token, enabling ecosystem governance, DeFi-based financing, and value transfe
Marjan and RAK Hospitality Holding Announce Landmark Merger to Shape The Future Of Ras Al Khaimah As A Global Destination for Lifestyle and Investment22.10.2025 17:17:00 CEST | Press release
Marjan, the master developer of freehold properties in Ras Al Khaimah, and RAK Hospitality Holding, the government-owned investment and development arm in the Emirate, have announced a landmark strategic merger to create a unified entity operating under Marjan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022275206/en/ Marjan and RAK Hospitality Holding Announce Landmark Merger To Shape The Future Of Ras Al Khaimah As A Global Destination For Lifestyle And Investment (Photo: AETOSWire) This merger combines world-class hospitality expertise with visionary land development strategies to form a dynamic future-ready organization. Marjan will integrate real estate development, hospitality operations, and lifestyle experiences under one umbrella, positioning itself as one of the largest real estate developers in the UAE and the leading master developer in the Northern Emirates. Announcing the merger, His Highness Sheikh Ahmed
Venture Global Statement on CP2 Final Approval22.10.2025 16:33:00 CEST | Press release
The U.S. Department of Energy issued the final non-FTA export authorization for Venture Global’s CP2 facility in Cameron Parish, Louisiana. Venture Global CEO Mike Sabel issued the following statement: “Venture Global is grateful for the Trump Administration’s final approval of CP2, a critical project that will supply American allies with low-cost LNG for decades, support thousands of jobs and greatly benefit the U.S. balance of trade. The CP2 project construction is well underway and we look forward to continue advancing the project safely and quickly to bring new LNG to the global market at a record pace beginning in 2027.” About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (LNG) with over 100 MTPA of capacity in production, construction, or development. Venture Global began producing LNG from its first facility in 2022 and is now one of the largest LNG exporters in the United States. The company’s vertically integrated bus
British Arab Commercial Bank Partners With Volante Technologies to Modernize Payments Infrastructure With PaaS22.10.2025 15:38:00 CEST | Press release
Volante’s cloud-native platform to unify BACB’s payment operations across SWIFT, CHAPS, Faster Payments, BACS, and more Volante Technologies, the global leader in Payments as a Service (PaaS), today announced a new partnership with British Arab Commercial Bank (BACB), to modernize the bank’s payment processing infrastructure and replace legacy systems with a cloud-native platform. BACB will use Volante’s PaaS solution to automate and streamline the entirety of its payments volumes across multiple payment schemes, including SWIFT MT/ISO 20022, CHAPS, Faster Payments, BACS, and internal transfers. Volante’s solution enables BACB to move beyond legacy systems and manual processes, empowering the bank to raise straight-through processing rates and continue to provide a first-class service to its customers. BACB is an international wholesale bank, with $4.4 billion in assets, who provide a range of trade solutions to clients trading in and out of developing markets, across Africa and the Mi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom